Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
While effective, their impact on multiple organs has raised concerns about long-term safety
doi: 10.1016/j.chembiol.2012.12.006 95 SchirmerAKennedyJMurliSReidRSantiDV
Who Should Consider IGF-1 LR3 IGF-1 LR3 is appropriate for: Experienced users already running a solid foundation (training, protein, sleep) People in an active recomposition phase wanting to accelerate lean muscle accrual Those already running or familiar with GH secretagogues who want to add direct IGF-1 receptor stimulation It's not appropriate for: Beginners who haven't first established a baseline with training and nutrition Anyone with active cancer history or elevated PSA (IGF-1 is mitogenic it drives cell growth, not selectively) People not monitoring blood glucose (hypoglycemia risk is real) Dosing Starting Dose 2030 mcg post-workout
Targeted assays aid in identifying candidate biomarkers by providing robust data with a high level of confidence in metabolite identity and are more appropriate for adaptation into clinical applications in terms of cost, reproducibility and overall feasibility
